Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
24.36
-1.03 (-4.06%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
271135--
Enterprise Value
199215--
Last Close Price
24.5712.00--
PB Ratio
4.322.15--
P/TBV Ratio
4.322.15--
Debt / Equity Ratio
0.190.19-2.08-1.40
Quick Ratio
7.147.143.112.78
Current Ratio
7.337.333.202.86
Return on Equity (ROE)
-59.37%-59.37%--
Return on Assets (ROA)
-18.39%-18.39%-61.63%-
Return on Capital (ROIC)
-22.38%-22.38%-110.58%-
Earnings Yield
-6.44%-12.95%--
Buyback Yield / Dilution
-24.08%-24.08%68.63%-
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q